CervoMed Inc. Net Income (Loss) Attributable to Noncontrolling Interest
CervoMed Inc. (CRVO) reported Net Income (Loss) Attributable to Noncontrolling Interest of $6.40 thousand for the 12-month period ending 2013-12-31, per its 10-K/A filed 2014-04-23.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2014-04-23
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-12-31 was $34.47K, a 37.70% increase year-over-year.
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-09-30 was -$13.63K, a 172.60% decline year-over-year.
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-06-30 was -$7.75K, a 9328.57% decline year-over-year.
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-03-31 was -$6.68K.
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2013 was $6.40K, a 66.45% decline from fiscal 2012.
- CervoMed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2012 was $19.08K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | $34.47K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $20.83K derived: sum of 2 quarters · filed 2014-04-23 | $13.08K derived: sum of 3 quarters · filed 2014-04-23 | $6.40K 10-K/A · filed 2014-04-23 | |
| 2013-09-30 | -$13.63K 10-Q · filed 2013-11-19 | -$21.39K derived: sum of 2 quarters · filed 2013-11-19 | -$28.07K 10-Q · filed 2013-11-19 | -$3.04K derived: sum of 4 quarters · filed 2014-04-23 | |
| 2013-06-30 | -$7.75K 10-Q · filed 2013-08-14 | -$14.43K 10-Q · filed 2013-08-14 | $10.60K derived: sum of 3 quarters · filed 2014-04-23 | $29.38K derived: sum of 4 quarters · filed 2014-04-23 | |
| 2013-03-31 | -$6.68K 10-Q/A · filed 2013-05-20 | $18.35K derived: sum of 2 quarters · filed 2014-04-23 | $37.13K derived: sum of 3 quarters · filed 2014-04-23 | $37.21K derived: sum of 4 quarters · filed 2014-04-23 | |
| 2012-12-31 | $25.03K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $43.81K derived: sum of 2 quarters · filed 2014-04-23 | $43.89K derived: sum of 3 quarters · filed 2014-04-23 | $19.08K 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $18.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $18.86K derived: sum of 2 quarters · filed 2013-11-19 | -$5.95K 10-Q · filed 2013-11-19 | ||
| 2012-06-30 | $84.00 10-Q · filed 2013-11-19 | -$16.20K 10-Q · filed 2013-08-14 | -$24.73K 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | -$16.20K 10-Q/A · filed 2013-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |